Many people on GLP-1 medications experience these problems
Primary site of GLP-1 secretion are L-cells in small intestine and colon, but it is also secreted by the pancreatic cells and neurons in nucleus tractus solitarus in the brainstem
This led to intensive research efforts focused on modifying the structure of GLP-1 to enhance its stability and prolong its action in the body
A person can carry an MTHFR or COMT variant and still have adequate current methylation, while another person with no major variant can develop low SAM, elevated SAH or impaired glutathione production
This ensures your diet supports and amplifies the benefits of your peptide therapy
BDF was found to regulate several key hormones, including an increase in gastrin and motilin while decreasing vasoactive intestinal peptides, thereby stimulating peristalsis and accelerating the transport of intestinal contents, as shown in Figure 2